| Net Cash Provided by (Used in) Operating Activities |
$108,142 |
USD |
-372% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$100,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
20,891,272 |
shares |
5.4% |
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,144 |
USD |
64% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$46,159 |
USD |
36% |
Q4 2025 |
Q2 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$939,839 |
USD |
-495% |
Q4 2025 |
Q2 2026 |
| Additional Paid in Capital |
$9,395,841 |
USD |
4.2% |
Q4 2025 |
Q2 2026 |
| Interest Expense |
$50,544 |
USD |
43% |
Q4 2025 |
Q2 2026 |